Tonix Pharmaceuticals Holding (TNXP) Price/Sales Ratio
Market Cap: $122.56M
Avg Volume: 1.64M
Industry: Biotechnology
Sector: Healthcare
What is Tonix Pharmaceuticals Holding's Price/Sales Ratio?
- Tonix Pharmaceuticals Holding's trailing twelve month (TTM) Price/Sales ratio is 12.14.
- Tonix Pharmaceuticals Holding's annual Price/Sales ratio as of today is 2.41.
- Tonix Pharmaceuticals Holding's quarterly Price/Sales ratio is 0.29.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess Tonix Pharmaceuticals Holding's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -0.19
- Quarterly: -0.01
- TTM: 0.00
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 0.17
- Quarterly: 0.01
- TTM: 0.00
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -0.40
- Quarterly: -0.05
- TTM: -0.01
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: 0.01
- Quarterly: 0.00
- TTM: 0.00
These metrics provide insights into Tonix Pharmaceuticals Holding's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
2.41
Quarterly Price/Sales Ratio
0.29
TTM Price/Sales Ratio
12.14
Tonix Pharmaceuticals Holding Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
Tonix Pharmaceuticals Holding Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2024 | 2.41 | -0.19 | 0.17 | -0.40 | 0.01 |
| 2023 | 88.40 | -5.89 | 6.51 | -6.73 | 0.09 |
| 2022 | 0.00 | -12.18 | 6.87 | -14.51 | 0.20 |
| 2021 | 0.00 | -141.24 | 59.60 | -172.51 | 2.61 |
| 2020 | 0.00 | -122.38 | 72.85 | -131.47 | 0.00 |
| 2019 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2018 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2017 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2016 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2015 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for TNXP.